Subjective and physiologic effects of intravenous buprenorphine in humans.
about
Buprenorphine: "field trials" of a new drug.Practical considerations for the clinical use of buprenorphine.Comparison of intravenous buprenorphine and methadone self-administration by recently detoxified heroin-dependent individuals.Self-administration of intravenous buprenorphine and the buprenorphine/naloxone combination by recently detoxified heroin abusers.Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience.Buprenorphine for opioid dependenceOpioid dependence treatment, including buprenorphine/naloxone.Buprenorphine and buprenorphine/naloxone diversion, misuse, and illicit use: an international review.Buprenorphine maintenance therapy in opioid-addicted health care professionals returning to clinical practice: a hidden controversy.Narrative review: buprenorphine for opioid-dependent patients in office practice.Methadone and buprenorphine-naloxone are effective in reducing illicit buprenorphine and other opioid use, and reducing HIV risk behavior--outcomes of a randomized trial.Design and evaluation of matrix-based controlled release tablets of diclofenac sodium and chondroitin sulphate.Acute pain control challenges with buprenorphine/naloxone therapy in a patient with compartment syndrome secondary to McArdle's disease: a case report and review.The Abuse Potential of Prescription Opioids in Humans-Closing in on the First Century of Research.Buprenorphine maintenance therapy in opioid-addicted health care professionals returning to clinical practice: a hidden controversy.Naltrexone and buprenorphine combination in the treatment of opioid dependence.Neuropsychological functioning of opiate-dependent patients: a nonrandomized comparison of patients preferring either buprenorphine or methadone maintenance treatment.Effects of buprenorphine on body temperature, locomotor activity and cardiovascular function when assessed by telemetric monitoring in rats.
P2860
Q31808981-88787698-5FA2-4C24-855F-1FB15216FCE8Q33774853-FCEEAC56-67AB-4B42-8BCD-A86A967D2B81Q33837582-BEA110B1-A698-4995-AA53-E82359FA279CQ33837609-5EFE9ACF-43C3-4BFD-B842-1CF6F7E4494CQ34081656-B2524EB4-259B-4493-96B8-700BF7624B05Q34119459-67EA856D-C96D-44EE-8D9A-C58665F15752Q34533873-2DE3485E-870F-4E2C-91D1-12727EE1A182Q35160035-D5AFBFAC-D033-48CF-91B1-C4803F4792C6Q36512881-A722CA3B-19E1-4BE0-A62D-1F5C6DC5D417Q36959052-8611D27C-F4D0-42C0-A2FA-4DAA7C27763DQ37282456-8E873AB0-8AA1-471D-9628-1151D5BA6874Q37360847-5FC82075-0DE3-401A-B41A-E26628CCEC76Q38104462-BBBB6CBF-6420-448E-93BC-EE05296AC99FQ38379235-A44ADA0C-01D0-4474-8035-6043BCB0595DQ42336042-90DC7E7D-4B26-4099-828E-40660F373E98Q44351532-1B00D2C9-D0E5-473D-A567-CFD51CAC283FQ46416517-CE36CD2C-D92C-4EC3-9CB8-936B842121C5Q46627599-A6B88ECC-EF77-4DD8-AD8B-D8A0A8563FFF
P2860
Subjective and physiologic effects of intravenous buprenorphine in humans.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh-hant
name
Subjective and physiologic effects of intravenous buprenorphine in humans.
@en
Subjective and physiologic effects of intravenous buprenorphine in humans.
@nl
type
label
Subjective and physiologic effects of intravenous buprenorphine in humans.
@en
Subjective and physiologic effects of intravenous buprenorphine in humans.
@nl
prefLabel
Subjective and physiologic effects of intravenous buprenorphine in humans.
@en
Subjective and physiologic effects of intravenous buprenorphine in humans.
@nl
P2093
P356
P1476
Subjective and physiologic effects of intravenous buprenorphine in humans.
@en
P2093
Holicky BA
Johnson RE
Pickworth WB
P304
P356
10.1038/CLPT.1993.72
P407
P577
1993-05-01T00:00:00Z